In the rapidly evolving field of biochemical research, the study of protein-protein interactions has opened new doors for understanding cellular signaling. My journey into this niche began with a fascination for the Hippo pathway and its regulatory components. Among the various compounds I have encountered, Peptide 17 stands out as a significant subject of study, particularly regarding its role as a YAP-TEAD protein-protein interaction inhibitor.
Understanding the Mechanism of Peptide 17
When analyzing Peptide 1 by SB Xu·2022·Cited by 6—Peptide 17 alleviates early renal injury in hypertensionby regulating the Hippo/YAP signalling pathway. These findings may be useful in the treatment of Read more 7, it is essential to recognize its structural classification. It is a 17mer peptide des The Hippo Pathway and YAP/TAZ–TEAD Protein–Protein igned to modulate the Hippo signaling pathway. In my review of the existing literature, I found it fascinating that Peptide 17 exhibits a binding affinity to TEAD1 (Kd = 15 nM) that is notably stronger than that of the native YAP (50-171) fragment (Kd = 40 nM). This high affinity makes it a precise tool for researchers looking to investigate the complex dynamics of YAP-TEAD-IN-1, which is a 17mer peptide frequently utilized in laboratory settings.
From my personal perspective, the specificity of these inhibitors is what makes them so valuable. Whether one is looking at YAP-TEAD Inhibitor 1 (Peptide 17) for cellular assays or exploring its biochemical properties, the precision afforded by an IC50 of 25 nM allows for highly controlled experimental envi YAP-TEAD Inhibitor 1 (Peptide 17)は、YAP-TEADタンパク質間相互作用阻害剤であり、IC50 25 nMでYAPが関与する癌の治療に用いられる可能性があります。Read more ronments.
Research Context and Applications
The dis YAP-TEAD Inhibitor 1 (Peptide 17) | CAS 1659305-78-8 course surrounding Peptide 17 often touches upon its potential in various research models. One of the most compelling areas of study involves how Peptide 17 alleviates early renal injury in hypertension. By regulating the Hippo/YAP signaling pathway, this compound provides a unique lens through which scientists can observe cellular responses to stress.
Furthermore, YAP and TAZ are TEAD coactivators (1, 17, 18) that play a pivotal role in maintaining cellular homeostasis. Because YAP1/TAZ signaling is crucial for cancer and wound healing, many researchers focus on how a YAP peptide can interfere with these pathways to inhibit unwanted proliferation. It is important to note that Peptide 17 is a inhibitor of this YAP-TEAD protein-protein interaction, and while some newer variants like YTP-17 is an orally active YAP-TEAD protein-protein interaction inhibitor are emerging, the original Peptide 17 remains a foundational reference point in molecular biology labs.
Observations on Quality and Efficacy
When sourcing high-purity reagents like Peptide 17, consistency is key. My experience indicates that the YAP-TEAD-IN-1 TFA is a 17mer peptide that requires careful handling to maintain its structural integrity. In my observations, the potency of the inhibitor is directly linked to the purity of the synthetic product. Researchers often compare this to other emerging molecules, such as those discussed in the broader context of best peptide for kidney repair or peptides for kidney repair, though Peptide 17 remains distinct due to its specific target.
Final Thoughts
The study of the Hippo pathway remains one of the most intellectually stimulating areas of modern research. Whether you are investigating the nuances o An allosteric pan-TEAD inhibitor blocks oncogenic YAP f Yap signaling or comparing different inhibitors, the by Z Zhou·2015·Cited by 174—This17mer peptidedemonstrates a single-digit micromolar affinity to TEAD1 (Fig. 1; Table 1). Point mutations onYAP peptidelike D93A (27) and Read more data surrounding peptide 17 provides a robust framework for scientific inquiry. It is a testament to the power of structure-bas TEAD-targeting small molecules induce a cofactor switch to ed design that a specific 17mer peptide can serve as such a potent interruptor of complex protein associations.
For those engaging in this field, staying updated on the latest citations regarding YAP-TEAD Inhibitor 1 (Peptide 17) is vital. As we continue to refine our understanding of these signaling cascades, the role of specialized inhibitors will undoubtedly become even more significant in uncovering the mysteries of signal transduction.